Atf6alpha impacts cell number by influencing survival, death and proliferation by Sharma, Rohit B. et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Open Access Articles Open Access Publications by UMMS Authors 
2019-09-01 
Atf6alpha impacts cell number by influencing survival, death and 
proliferation 
Rohit B. Sharma 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/oapubs 
 Part of the Amino Acids, Peptides, and Proteins Commons, Biological Phenomena, Cell Phenomena, 
and Immunity Commons, Cell Biology Commons, Cells Commons, Cellular and Molecular Physiology 
Commons, and the Molecular Biology Commons 
Repository Citation 
Sharma RB, Snyder JT, Alonso LC. (2019). Atf6alpha impacts cell number by influencing survival, death 
and proliferation. Open Access Articles. https://doi.org/10.1016/j.molmet.2019.06.005. Retrieved from 
https://escholarship.umassmed.edu/oapubs/3994 
Creative Commons License 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles 
by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
Atf6a impacts cell number by influencing
survival, death and proliferation
Rohit B. Sharma, Jarin T. Snyder, Laura C. Alonso*
ABSTRACT
Background: A growing body of literature suggests the celleintrinsic activity of Atf6a during ER stress responses has implications for tissue cell
number during growth and development, as well as in adult biology and tumorigenesis [1]. This concept is important, linking the cellular
processes of secretory protein synthesis and endoplasmic reticulum stress response with functional tissue capacity and organ size. However, the
field contains conflicting observations, especially notable in secretory cell types like the pancreatic beta cell.
Scope of review: Here we summarize current knowledge of the basic biology of Atf6a, along with the pleiotropic roles Atf6a plays in cell life and
death decisions and possible explanations for conflicting observations. We include studies investigating the roles of Atf6a in cell survival, death
and proliferation using well-controlled methodology and specific validated outcome measures, with a focus on endocrine and metabolic tissues
when information was available.
Major conclusions: The net outcome of Atf6a on cell survival and cell death depends on cell type and growth conditions, the presence and
degree of ER stress, and the duration and intensity of Atf6a activation. It is unquestioned that Atf6a activity influences the cell fate decision
between survival and death, although opposite directions of this outcome are reported in different contexts. Atf6a can also trigger cell cycle
activity to expand tissue cell number through proliferation. Much work remains to be done to clarify the many gaps in understanding in this
important emerging field.
 2019 Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. INTRODUCTION
The mammalian unfolded protein response (UPR) is an elegant cellular
process originating in the endoplasmic reticulum (ER) which adapts ER
protein folding capacity to meet protein folding load [2,3]. The ER is a
critical multifunctional cellular organelle with roles including secretory
protein synthesis, folding, quality control and targeting; calcium ho-
meostasis; and glucose and lipid metabolism. Like many other bio-
logical systems, ER mass and function are actively determined by the
relative rates of catabolic destruction and de novo synthesis [2,3].
The UPR, triggered by ER stressors such as excess unfolded pro-
teins, redox imbalance, or calcium depletion, is the principal
regulator of ER expansion. The biology of the UPR, which is
conserved across phyla, has been extensively reviewed [2e6].
Three ER transmembrane proteins, Perk, Ire1 and Atf6a, respond to
ER stress and activate a coordinated translational and transcrip-
tional program to slow new peptide entry into the ER, enhance ER
associated degradation of misfolded protein, and increase biosyn-
thesis of ER components to expand ER capacity. If the adaptation is
successful, the cell resumes function at a new higher capacity.
However, if adaptation fails, unresolvable ER stress and chronic
UPR activation lead to cell death [7].
The original understanding of the UPR was as a cell-autonomous
mechanism by which a cell adapts secretory-pathway protein pro-
duction capacity to demand. However, emerging evidence suggests
important roles for the UPR at the level of complex tissues and even
whole organism health and metabolism, by influencing tissue function
and cell number through death, survival, and proliferation decisions
[5,6]. Of the three ER transmembrane proteins sensing stress and
initiating the UPR, Atf6a may be the least well understood. Roles of
Atf6a in organogenesis and development have been reviewed [1]. Here
we summarize current understanding of the roles played by Atf6a in
influencing cell proliferation and death, with attention paid to con-
flicting conclusions and possible explanations. When possible, we
focus on data generated in primary tissues and cancers.
2. OVERVIEW OF ATF6a BIOLOGY
Atf6a was identified as an ER stress response mediator in 1998 in the
laboratory of Kazutoshi Mori in Kyoto, Japan, using a yeast-one-hybrid
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screen with a promoter element found to be common to genes
upregulated by the UPR [8]. Initially found to be an activating tran-
scription factor (ATF) family member that weakly bound a cAMP
response element [9] and an SRF-binding protein [10], Atf6a is now
known to be a member of a family of stress-responsive bZip tran-
scription factors called OASIS factors [11]. The pace of Atf6a-related
discovery has accelerated recently; most papers on the function of this
important factor have been published in the past 5 years.
2.1. ATF6a gene structure
The human ATF6a gene, conserved across plants and metazoans [12],
is located on chromosome 1. ATF6a contains only a single protein-
coding transcript, with 16 exons and no known splice isoforms,
which codes for the 670aa ATF6a protein (Figure 1). The mouse Atf6a
gene is also encoded on chromosome 1, also contains 16 exons with
no known splice variants, and encodes a 656aa protein.
2.2. Atf6a protein size and intracellular localization
In unstressed human cells, ATF6a protein is detected at a 90 kDa size,
larger than the calculated molecular weight of 74.6 kDa [8]. However,
during ER stress conditions, such as exposure to the glycosylation
inhibitor tunicamycin or SERCA inhibitor thapsigargin, Atf6a-directed
antibodies detect an additional 50 kDa band [8,13]. Indirect immu-
nofluorescence, cellular fractionation and tryptic digestion studies
determined that p90Atf6a is a type II transmembrane ER resident
glycoprotein with a single-pass hydrophobic transmembrane domain
of 21aa near the middle of the protein [13,14]. In contrast, p50Atf6a is
a soluble, short-lived nuclear protein that is most easily detected in the
presence of the ALLN protease inhibitor [13e16]. Studies with mutant
constructs suggest that the presence or absence of the trans-
membrane region determines the localization of the N-terminal
(p50Atf6a, aa 1e373) domain, suggesting a model in which a
cleavage event releases the cytosolic domain from the transmembrane
and luminal domains, resulting in nuclear localization [13]. The
structural elements of Atf6a are summarized in Figure 1.
2.3. p90Atf6a transit to Golgi during ER stress
Although full length p90Atf6a contains two Golgi localization signals
[17], during normal conditions it is found in the ER [13,14]. The 272aa
ER luminal domain is sufficient to sense stress, relocate the protein to
the Golgi, and allow cleavage [18]. Stress sensing occurs through
interaction with the Grp78 (also called BiP, Hspa5) chaperone [17]. In
unstressed conditions Atf6a is retained in the ER by interaction with
Grp78, but during stress Grp78 is titrated away, releasing Atf6a to
proceed to the Golgi in a COPII dependent mechanism [19]. Transport
is regulated; even with excess unfolded proteins in the ER, Atf6a is
selectively allowed to move to the Golgi while unfolded proteins are
retained in the ER [20]. In a pancreatic beta cell line, Atf6a trans-
location to Golgi required Sar1A, a small GTPase involved in COPII
vesicle formation [21].
2.4. Mechanism of p90Atf6a cleavage in the Golgi
The mechanism of the Atf6a cleavage event was clarified by Brown
and Goldstein [15]. Similarly to SREBP, p90Atf6a undergoes regulated
intramembrane proteolysis, in which S1P first cleaves the peptide on
the luminal side of the transmembrane domain, and then S2P cleaves
the peptide within the transmembrane domain, liberating the cyto-
plasmic soluble domain [15]. In support of this model, a serine pro-
tease inhibitor had no impact on transit of p90Atf6a to the Golgi, but
prevented Atf6a cleavage and target activation [22]. A novel feedback
loop has been described, in which Atf6a transcriptional target and key
Golgi calcium regulator Nucleobindin 1 inhibits S1P Atf6a cleavage,
without impacting transit to Golgi [23]. In neurons, Calsenilin, encoded
by the KCNIP3 gene, regulates ATF6a processing and mediates pro-
tection by repaglinide on Huntington’s disease [24].
2.5. Protein modifications impact Atf6a behavior
Post-translational modifications also impact Atf6a transport and acti-
vation by ER stress. Under unstressed conditions Atf6a is found in
monomeric, dimeric and multimeric complexes due to intra- and inter-
molecular disulfide bonds [25]. Only reduced monomeric Atf6a transits
to Golgi, but reduction was not sufficient to induce activation [25]. An
siRNA screen for Atf6a activators in cancer cells identified a novel
mechanism in which the protein disulfide isomerase Pdia5 promotes a
disulfide bond rearrangement in the luminal domain of Atf6a, leading
to Atf6a packaging in CopII vesicles [26]. Intriguingly, the Atf6a
luminal domain has three conserved N-linked glycosylation sites, and
glycosylation provides a negative signal, restricting Atf6a respon-
siveness to stress [27]. Under-glycosylated forms of Atf6a achieved by
mutation of the glycosylation sites leads to reduced interaction with ER
Figure 1: Schematic of the Atf6a protein, with known domain structures and functional elements. nAtf6, nuclear Atf6. S1P, site 1 protease. S2P, site 2 protease. VP16,
herpes simplex virus protein vmw65 activating domain. Data contributing to this figure are from [13,15e17,25,51].
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chaperone calreticulin and increased transit to Golgi, cleavage, and
transactivation of target genes [27]. The role of stress kinases is
controversial; one study found that p38-Mapk phosphorylated Atf6a at
Thr-166, preventing cleavage and nuclear translocation [28]; in other
conditions p38-Mapk phosphorylation of the N-terminal cytoplasmic
domain was found to enhance Atf6a transcriptional activation of tar-
gets such as Grp78 [29,30].
2.6. Atf6a abundance is also regulated at the RNA level
In addition to the well-known protein-level activation by ER stress
described above, Atf6a is also itself increased at the RNA level by ER
stress. In MEFs, Atf6a mRNA was increased by tunicamycin exposure
in sXbp dependent fashion [31]. On the other hand, thapsigargin was
observed to increase Atf6a mRNA in a feed-forward autoregulation
loop via Atf6a binding elements in the Atf6a promoter [32]. The
proteasome-regulating transcription factor Nrf1, and ERRg, also
positively regulate Atf6a gene transcription through direct enhancer
binding [33,34].
2.7. Nuclear p50Atf6a regulates gene transcription through direct
DNA binding
Cleavage of Atf6a in the Golgi releases p50Atf6a, a 373aa cytoplasmic
fragment which contains a basic leucine zipper DNA binding domain and
several putative nuclear localization signals, and localizes to the nucleus
[8,13e15]. As such, ER stress-induced transit and cleavage of Atf6a
activates an ER-to-nucleus transcriptional regulatory program. The first
identified DNA regulatory sequence bound by Atf6a was a 19 nucleotide
motif, CCAATN9CCACG, called the ER stress response element (ERSE)
[8]. This bipartite motif contains a CCAAT box, bound by general factors,
and a CCACG box, bound by Atf6a [8,35,36]. Subsequently, Atf6a was
found to also bind to TGACGTG(G), now called the UPRE, which contains
a partial complement of the ERSE sequence [36]; however, the UPRE is
now considered to be more responsive to sXbp1 than Atf6a [37]. A third
ER stress response element, ERSE-II, ATTGG-N-CCACG, contains the
Atf6a-binding CCACG box next to an inverted CCAAT box with a much
shorter spacer of only one base pair [37].
ERSE motifs are found in known ER stress responsive genes Grp78,
Grp94 and calreticulin, and mediate stress-responsive transcription of
a luciferase construct [8]. Base-by-base mutation mapped the ERSE
critical nucleotides [8]. The bipartite ERSE motif engages general
transcription factors YY1 and NF-Y/CBP at the CCAAT box; Atf6a binds
at the CCACG box [8,35,36]. Atf6a interacts with the C-subunit of NF-Y
[38]; co-binding of NF-Y and YY1 added selectivity and strength to the
Atf6a transcriptional response [14]. In addition to SRF, NF-Y and YY1,
Atf6a may regulate gene transcription by interacting with PGC1alpha
[34]. Mutation of the bZip DNA binding domain eliminated trans-
activation of a Grp78-ERSE luciferase reporter [16]. Atf6a (1e373)
transcription transactivating activity is mostly contained in a VP16-like
domain at aa 1e38 and 52e93 [16].
2.8. Cross-talk between Atf6a and other UPR pathways
Teasing out the role of Atf6a in the UPR transcriptional response is
complicated by overlapping functions of other UPR nuclear effectors,
especially sXbp1 [39]. In general, the UPRE motif is activated by sXbp1,
whereas ERSE and ERSE-II are activated by both sXbp1 and Atf6a [37].
In the presence of NF-Y, sXbp1 can replace Atf6a at the ERSE, but with
lower binding efficiency [37]. Complicating matters, Atf6a transcrip-
tionally induces Xbp1 [40], but may suppress Ire1 mRNA levels [41].
Further confounding separation of roles, Atf6a heterodimerizes with
sXbp1, binding the UPRE with 8-fold higher affinity than sXbp1
homodimer [42].
Atf6a has a homologue, Atf6b, that shares similar biology: full length
Atf6b is ER membrane localized and upon ER stress transits to Golgi,
undergoes cleavage by S1P/S2P and releases an N-terminal tran-
scription factor [43]. Atf6b exhibits some degree of functional redun-
dancy with Atf6a, since gene deletion of either Atf6a or Atf6b has
minimal biological impact but deletion of both Atf6a and Atf6b is
embryonic lethal [42]. However, in vitro studies show important dif-
ferences. Atf6a is solely responsible for the classical UPR-dependent
gene regulation [42,44]; in fact, Atf6b has been reported to antago-
nize some Atf6a actions, such as transcriptional induction of Grp78
[45,46].
Atf6a also has a complex relationship with UPR death effector Chop.
Atf6a transcriptionally induces Chop mRNA [47,48]. However, over-
expression of Chop suppressed Atf6a activation of target gene Grp78
in dose-dependent manner. Chop is also a bZip transcription factor and
may heterodimerize with Atf6a to suppress its activity [49]. On the
other hand, CHIP assay showed that Chop binds to the Grp78 promoter,
and a mutant Chop defective in DNA binding failed to suppress Atf6a
mediated Grp78 induction, favoring a model in which Chop inhibits
Atf6a gene regulation by competing for the regulatory motifs [49].
2.9. Canonical function of Atf6a
The principal outcome of Atf6a activation during ER stress is the
expansion of functional ER capacity. Atf6a transcriptionally upregu-
lates many genes involved in protein folding, including ER-resident
chaperones, foldases, calcium transport proteins, and oxidation/
reduction regulators [1,39,42]. Atf6a is also required for optimal
clearance of misfolded proteins via Endoplasmic Reticulum-Associated
Degradation (ERAD) genes and for expansion of the ER through in-
duction of membrane synthesis [1,50]. Atf6a promotes ER expansion
via heavily redundant and overlapping roles with the other UPR path-
ways, such that disentangling one from the others is challenging
[2,4,39].
2.10. Mechanisms turning the Atf6a signal off
Full length p90Atf6a is subject to ubiquitination and proteasomal
degradation, more pronounced after ER stress induction [51]. WFS1,
an ER transmembrane protein mutated in Wolfram syndrome, was
found to suppress Atf6a activation by inducing proteasome-mediated
degradation of full-length Atf6a [52]. Supporting a role for chronic
activation of Atf6a in Wolfram syndrome, Atf6a levels were increased
in both Wfs1-deleted mice and Wolfram patient samples [52]. In
addition, p90Atf6a was identified as a transmembrane target of ERAD,
requiring both ERAD E3 ligase Sel1l and mannose trimming [50].
Nuclear Atf6a is short-lived, requiring protease inhibition to detect,
suggesting a rapid degradation mechanism [13e16]. Observing that
protein stability of N-terminal Atf6a mutants was correlated with
transcriptional activity, the VP16-homologous domain identified by
Christopher Glembotski’s group was found to confer both trans-
activation and degradation capacity [16]. Intriguingly, the unspliced
form of Xbp1 mRNA is also translated to a protein product, which
accumulates in later stages of UPR recovery and may be responsible
for targeting sXbp1 and nAtf6a for proteasome mediated degradation,
implicating an Ire1-derived off-signal in shutting down the sXbp1 and
nAtf6a transcriptional programs [53].
3. CONFLICTING ROLES: ATF6a CAN PROMOTE BOTH CELL
SURVIVAL AND CELL DEATH
Atf6a has been reported to play numerous, disparate roles in pro-
cesses regulating cell number (Figure 2). In its canonical role, Atf6a
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activation drives a multi-pronged and robust effort by the cell to restore
protein folding capacity, export misfolded protein from the ER for
degradation by the proteasome, and ultimately, promote cell survival in
response to diverse insults to the ER folding environment [44]. This
pro-survival function may drive the pathology of achromatopsia, a
genetic human retinal disease resulting from ATF6a mutations [54].
Mutations that impair ATF6a activation by disrupting ER-Golgi traf-
ficking, regulated intramembrane proteolytic cleavage or transcrip-
tional activity were found to increase cell death in patient-derived
fibroblasts, although a role for cell death in achromatopsia patho-
genesis remains uncertain [54].
On the other hand, Atf6a has also been found to increase cell death,
through direct and indirect mechanisms, supporting a pro-apoptotic
role for Atf6a under some conditions. Atf6a induces expression of
Chop, which drives apoptosis through various mechanisms. A tissue
highlighting the complicated coexisting pro- and anti-apoptotic func-
tions of Atf6a is the pancreatic beta cell. For example, pathogenesis of
Wolfram Syndrome, a progressive neurological syndrome character-
ized by hearing loss, optic atrophy and diabetes, may be due to ATF6a
toxicity [52]. WFS1 provides feedback inhibition on ATF6a signaling,
via targeting full length ER ATF6a for proteasomal degradation by
recruiting the HRD1 E3 ligase [52]. Loss of function of WFS1 in
Wolfram Syndrome causes pancreatic beta cell dysfunction, apoptosis
and diabetes through dysregulated excess ATF6a activity [52]. ATF6a
was also implicated in the transcriptional response to lipotoxicity
leading to human beta cell death [55]. On the other hand, loss of Atf6a
was reported to cause beta cell death in a type 1 diabetes model, and
cell death was decreased by restoration of Atf6a expression [56].
Known mechanisms of pleiotropic pro-survival and/or pro-cell death
Atf6a functions are reviewed below.
4. ATF6a PROMOTES CELL SURVIVAL
4.1. Atf6a promotes cell survival by adapting protein folding
capacity during ER stress
As noted above, the primary function of Atf6a is as an ER membrane
sensor, detecting misfolded proteins in the ER lumen and activating a
transcriptional response to restore protein folding homeostasis. Effi-
cient ER function requires the activity of many genes that Atf6a con-
trols, including protein folding chaperones, foldases, [Ca2þ]-regulatory
and -regulated ER proteins, redox regulators, as well as other
miscellaneous genes with unclear roles in the UPR [2,4,13,14,57,58].
One of the earliest studies of Atf6a revealed that ER Ca2þ-ATPase
inhibitor thapsigargin activates cleavage of Atf6a to induce protein
folding chaperones [13]. Overexpressed ATF6a cooperates with gen-
eral transcription factors NF-Y or YY1 to bind the ERSE and induce
expression of ER chaperones GRP78, GRP94, and calreticulin, among
many other genes later identified [14,47]. Conversely, deletion of Atf6a
in MEFs severely reduced the ER-stress dependent induction of a suite
of ER chaperone genes: Grp78, Grp94, Grp170, p58IPK, and Erdj3 [57].
In addition to chaperones, Atf6a also increases membrane phospha-
tidylcholine synthesis which may help to increase folding capacity by
increasing ER volume [59].
Some Atf6a-dependent chaperones are critically important for cell
survival; chaperone deletion may induce apoptosis despite activation of
UPR [60e62]. In addition to chaperone, calcium and UPR-inhibitory
actions, Grp78 directly binds and inhibits ER-resident Bik pro-
apoptotic activity, preventing binding of Bcl2 [63,64]. Homozygous
loss of chaperone expression can cause embryonic lethality or severe
developmental defects. For example, deletion of Grp78 is lethal very
early in development, around the time of embryo implantation into the
Figure 2: Summary of Atf6a-regulated pathways regulating cell fate decisions leading to cell death, cell survival or proliferation. S1P, site 1 protease. S2P, site 2
protease. Chop, C/EBP homologous protein. Jnk, c-Jun N-terminal kinase. Runx2, Runt-related transcription factor 2. Bcl-2, B-cell lymphoma 2. Vegf, Vascular endothelial growth
factor. cFos, human homolog of FinkeleBiskiseJinkins murine osteogenic sarcoma virus oncogene. Rheb, Ras homolog, mTor binding. ERAD, ER associated degradation. mTor,
mammalian target of rapamycin. Please see the text for citations.
Review
S72 MOLECULAR METABOLISM 27 (2019) S69eS80  2019 Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
www.molecularmetabolism.com
uterine wall, with excess apoptosis in the inner cell mass [60]. Loss of
function in chaperone p58IPK causes diabetes and neurodegenerative
disorders in mice and is linked to a similar syndrome in rare familial
cases [65]. Intriguingly, in addition to ER-resident chaperone expres-
sion, Atf6a may also control extracellular protein folding via increased
transcription and secretion of chaperone ERdj3, which functions both
intracellularly and extracellularly to prevent aggregation of unfolded
proteins [66]. Overexpressed ERdj3 reduced extracellular amyloid beta
aggregation, and secreted ERdj3 in conditioned media prevented
vacuolization in a neuroblastoma line treated with toxic prion protein.
As such, Atf6a-mediated induction of chaperones may be important
for both intracellular and extracellular proteostasis.
4.2. Atf6a influences ER redox status
Atf6a pro-survival functions also include maintenance of healthy ER
redox status. Atf6a controls the expression of several ER-resident
proteins that catalyze the formation and breakage of disulfide bonds
during protein folding [67], such as Erp72, p5, & Ero1beta [42,57].
These oxidoreductases are oxygen-dependent enzymes that that may
link hypoxia to UPR activation [68]. Atf6a has a well-supported role in
promoting adaptation to hypoxic stress. Atf6a knock-in reduced ne-
crosis and apoptosis and improved heart function after ischemia/
reperfusion injury [69]. Conversely DN-Atf6a or siAtf6a increased
apoptosis in response to ischemia/reperfusion in cardiac myocytes
[70]. Pdia6 is an Atf6a target that promotes chemotherapeutic resis-
tance in cancer and protects against ischemia/reperfusion injury in
cardiomyocytes when overexpressed [71,72]. Atf6a-dependent in-
duction of antioxidant genes has also been reported to be protective in
cardiac ischemic/reperfusion injury [73] but an antioxidant function of
Atf6a has not been confirmed in other studies. Besides the heart,
Atf6a also appears protective against ischemia/reperfusion injury in
the brain. In a surgically-induced murine stroke model, overexpressed
Atf6a reduced infarct size and improved cognition, associated with
upregulated Bcl2 and accelerated induction of autophagy [74]. Inter-
estingly, the usually pro-apoptotic Atf6a target Chop may actually be
protective in hypoxic neurons [75].
4.3. Atf6a targets improve clearance of ER misfolded proteins
Atf6a also promotes cell survival by transcriptionally activating ER-
associated degradation pathways (ERAD) that clear misfolded pro-
teins from the ER. Atf6a and Xbp1 knockout MEFs show an inability to
induce canonical ERAD genes HerpUD1, Edem, and Hrd1 in response
to ER stress, along with a decrease in viability compared to wild type
cells [42]. ATF6a also induces Derlin-3, an important ERAD component
that facilitates extrusion of misfolded proteins into the cytosol for
proteasomal degradation [76,77]. Derlin-3 improved clearance of
misfolded protein from the ER and was necessary and sufficient to
reduce apoptosis in rat cardiomyocytes that underwent simulated
ischemia/reperfusion injury [76].
4.4. Atf6a influences autophagy
ATF6a may also improve cell survival by inducing autophagy, clearing
misfolded proteins and damaged organelles. As noted in 4.2, over-
expression of nuclear Atf6a protected mice against stroke, with early
induction of autophagy [74]. Ormld3 knockout splenic B cells had
decreased Atf6a and Beclin1 expression, with reduced survival;
overexpression of ATF6a rescued Beclin1 expression, autophagy, and
survival [78]. Atf6a can also interact with C/EBP-beta to trigger
autophagy through induction of Dapk1 in response to bacterial insult or
IFNg. In support of the importance of this observation, Atf6aKO mice
are susceptible to death from bacterial infection [79]. Phosphorylation
of Atf6a by Ask1/Mkk3-p38Mapk pathway was necessary for its
activation and subsequent interaction with C/EBP-beta to mediate IFNg
induced Dapk1 [28]. Similarly, in the mouse neuroblastoma line
Neuro2, Japanese encephalitis virus infection induced Atf6a and
Xbp1-dependent autophagy, preventing apoptosis [80]. In this model
system Xbp1, but not Atf6a, was necessary for Beclin-1 induction,
while Atg3 was Atf6a-dependent. An intriguing hypothesis is that
Atf6a could have evolved in part as a defense mechanism against
pathogen-induced ER stress. On the other hand, ER-stress induced
autophagy was unaffected by knockdown of Atf6a in the human
neuroblastoma line SK-N-SH but was instead dependent on the Ire1-
Jnk pathway [81], and siAtf6a had no effect on Dengue-virus
induced autophagy [82].
4.5. Atf6a may affect survival through activation of mTor
Atf6a was required for mTor activation in a Drosophila cell line [83].
Atf6a promoted chemotherapeutic resistance of dormant squamous
carcinoma through Akt-independent mTor activation via transcrip-
tionally inducing mTor-activator Rheb [84]. Furthermore, in endothelial
cells, Vegf induced Atf6a was required for pro-survival Akt phos-
phorylation by mTor [85].
4.6. Atf6a has a limited role under unstressed conditions
Surprisingly, considering the implied importance of this supposedly
critical UPR component, under unstressed conditions Atf6a-null mice
are remarkably normal. Individual Atf6a or Atf6b-null mice appear
viable and healthy, but deletion of both genes results in embryonic
lethality, suggesting that Atf6a and Atf6b have redundant functions
such that Atf6b can replace Atf6a under basal conditions [42,44]. One
cell type that may require Atf6a under unstressed conditions is the
pancreatic beta cell; in normoglycemic conditions, anti-Atf6a siRNA-
treated insulinoma cells had a JNK-dependent increase in apoptosis
[86]. Although Atf6a knockdown in these cells reduced Atf6a protein
by only around 60%, this reduction was sufficient to reduce Grp78
mRNA and protein expression under basal conditions. Other Atf6a
targets Grp94 and ERAD component Herp were only blunted during
induction of ER stress. On the other hand, whole body Atf6a-null mice
had no discernible impairment in glucose metabolism except under
insulin-demand stress conditions [87].
4.7. Atf6a is required for resilience in the face of stress
When exposed to stress conditions, Atf6a-null cells have impaired
stress resistance. Although Atf6a knockout MEFs had no significant
difference in chaperone expression or viability when cultured in normal
growth medium, induction of chaperones was blunted after treatment
with ER stress-inducing drugs, and viability was decreased [44]. Atf6a
is also critical for the acute adaptive response to ER stress in vivo.
Challenging Atf6a-null mice with intraperitoneal tunicamycin resulted
in macroscopic liver damage and a dramatic 80% mortality (compared
to 0% in wild type mice), along with reduced and delayed induction of
ER-chaperone and ERAD genes. Pancreatic beta cells in Atf6a-null
mice also showed impaired function under insulin demand stress [87].
Taken together, it seems the impact of Atf6a depletion requires acute
stress to be revealed [44].
In contrast, it has been reported that Atf6a is not required for induction
of UPR genes by ER stress in stable anti-Atf6a siRNA-expressing MEFs
[31]. The authors postulated that transcription factors related to Atf6a
(Atf6b or other family members) may compensate for Atf6a loss.
Although the authors reported that residual Atf6a activity was unlikely,
due to undetectable Atf6a expression in the Atf6a knockdown cells,
nuclear Atf6a is a potent and short-lived transcription factor [16].
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Therefore, it is possible that some Atf6a may have been present but
not detected. This is consistent with another study using Atf6a siRNA
in liver Kupffer cells that showed Tm-induced upregulation of Xbp1,
Chop, and Grp78 was unaffected by Atf6a KD in which p50-Atf6a was
decreased but still detectable after knockdown [88].
5. IN OTHER CONTEXTS, ATF6a INCREASES APOPTOSIS
Contradictory to its reported pro-survival role, in certain contexts Atf6a
has been shown to activate the intrinsic mitochondrial apoptosis
pathway, possibly related to supra-physiological Atf6a activation.
Ectopically expressed Atf6a directly bound an ERSE in the Bcl-2
promoter to repress its expression [89]. Overexpressed Atf6a
decreased viability of vascular endothelial cells exposed to thapsi-
gargin [90]. Atf6a may also regulate intrinsic apoptosis through
downregulation of E2f1 expression, the loss of which was sufficient to
increase expression of Puma and Noxa [91]. In mouse granulosa cells,
knockdown of Atf6a decreased p53 and apoptosis [92]. In contrast,
knockdown of Xbp1 increased apoptosis [93]. Overexpression of nu-
clear Atf6a in differentiating myoblasts upregulated a WW-domain
binding protein (Wbp1) and downregulated anti-apoptotic Mcl-1,
which was sufficient to increase apoptosis [94].
5.1. Atf6a increases expression of Chop
The most widely supported pro-death signal downstream of Atf6a is
the transcription factor Chop (Ddit3, Gadd153). Atf6a cooperates with
the Perk/Atf4 pathway to induce maximal expression of Chop in
response to ER stress [95]. Chop knockout MEFs have delayed
apoptosis after exposure to tunicamycin [96]. Similarly, tunicamycin-
induced apoptosis was reduced, but not eliminated, in the kidney
proximal tubular epithelium of Chop-null mice. Chop loss of function is
protective in models of diabetes [97e100], neurodegenerative disease
[101,102], renal injury [103e107], and sepsis [108].
Chop induces cell death through several mechanisms. Like Atf6a,
Chop directly controls expression of components of the intrinsic
apoptosis pathway. It is reported to downregulate pro-survival Bcl2
[109] and increase expression of pro-apoptotic Puma and Bim [110].
Via induction of Gadd34, Chop antagonizes the p-eIF2a-mediated
translation block to increase protein synthesis even though the protein
folding capacity may not have been adequately restored [103,111].
Furthermore, Ero1a is activated by Chop and contributes to oxidative
stress in the ER which sensitizes cells to undergo apoptosis [103,111].
The Atf4/Chop pathway could define a switch from anti-apoptotic to
pro-apoptotic signaling with longer stress duration, with the short half-
life of pro-apoptotic mRNAs providing protection against cell death
early during adaptive UPR [112].
5.2. Atf6a-induced autophagy promotes cell death
As described above, Atf6a-dependent autophagy can be protective in
some cases but leads to autophagic cell death in other contexts. In
MCF7 cells, siRNA silencing of ATF6a, IRE1, or dnPERK, inhibited
doxorubicin-induced autophagy and apoptosis [113]. Knockdown of
ATF6a also prevented berberine-induced elevation of GRP78 in cancer
cell lines, which was required for induction of autophagy and cell death
[114].
5.3. Atf6a leads to inflammation
In addition to the well-studied effects on Chop and intrinsic apoptosis
pathways, Atf6a also modulates inflammatory and immunogenic cell
death. Atf6a promoted NF-kB activation and pro-inflammatory cyto-
kine expression in liver Kupffer cells to promote liver damage during
ischemia/reperfusion injury [88]. On the other hand, Atf6a-induced
sXbp1 prevents Tnf-a induced apoptosis in osteoarthritic cartilage
[115], and Atf6a was necessary for suppression of Tnfa-induced NF-
kB activation via upregulation of C/EBPb and activation of mTor, which
prevented Akt phosphorylation [116].
5.4. How can Atf6a be both pro- and anti-cell survival?
The many seemingly contradictory findings with regard to the down-
stream effects of Atf6a may have multiple explanations. Hetero-
dimerization with other transcription factors could provide cell-type
specificity for Atf6a target genes, leading to different results in
different cell types. Post-translational modifications may also provide
context-specificity of Atf6a activity. Cell-type specific epigenetic
landscapes could prime or block activation of Atf6a target genes. In
addition, the ability of Atf6b to compensate for Atf6a loss may vary by
cell type. Secretory cells such as pancreatic beta cells may be espe-
cially dependent on Atf6a to cope with the high basal ER function
requirement inherent in synthesizing proteins for systemic use. The
duration and intensity of Atf6a activation may clearly play a role in the
switch between pro-survival and pro-apoptotic UPR signaling, and
some differences in results may be due to excess overexpression.
Specific underlying mechanisms explaining divergent effects of Atf6a
require further study.
6. ATF6a ALSO MODULATES CELL PROLIFERATION
In addition to the canonical Atf6a downstream response leading to
expanded ER proteosynthetic capacity, and the extensive evidence that
Atf6a modulates cell survival, some studies have found that Atf6a
action also influences the decision to enter the cell cycle. Some of the
work implicating Atf6a in proliferation has been performed in cancer or
cancer cell lines [117e122]; other observations are in primary tissues
such as pancreatic beta cells, ovarian cells, chondrocytes and car-
diomyocytes [46,92,123e125]. In most cases, Atf6a activation
increased cell cycle entry, whether as part of healthy tissue growth and
adaptation or as a maladaptive response to disease. Some data show a
role for Atf6a in tissue hypertrophy without hyperplasia [125e127]. An
anti-proliferative effect has been described as well [128]. Since pro-
liferation of normal tissues may be part of healthy adaptation or
maladaptation, and proliferation of cancer cells leads to disease, Atf6a
roles in proliferation defy categorization as uniformly beneficial or
harmful. What little is known of the mechanisms by which Atf6a
activation influences cell proliferation is summarized below.
6.1. Decreasing Atf6a signaling inhibits cancer cell proliferation
Endoplasmic reticulum stress, and the UPR, are well-established
features of cancer biology related to insults such as hypoxia, poor
nutrient availability relative to metabolic demand, and oxidative stress
[129]. Although the majority of studies investigating ATF6a in cancer
cells have focused on oncogenic cell survival in the face of ER stress,
there is evidence that ATF6a promotes proliferation as well. ATF6a,
known to be a tumorigenic factor in hepatocellular carcinoma [130],
drives proliferation and BrdU incorporation in hepatoma cells in a
proteostasis-stress dependent manner [118]. Treating cells with a
proteasome inhibitor oprozomib decreased proliferation by inhibiting
regulated intramembrane proteolysis, thus reducing ATF6a cleavage
and decreasing ATF6a target gene activation [118]. Similarly, the
antiretroviral protease inhibitor nelfinavir was found to have anti-
proliferative effects in prostate cancer and liposarcoma through an
off-target inhibition of S1P/S2P activation of ATF6a [121,122]. In
addition, knockdown of ATF6a in glioblastoma cells reduced
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proliferation, although the observation was weakened by use of a
nonspecific viability assay to quantify proliferation [120]. These studies
suggest that decreasing ATF6a expression or activation reduced
proliferation, supporting a pro-proliferative role for ATF6a in human
cancers, although downstream mechanisms were not tested.
6.2. Increasing Atf6a signaling drives cancer cell proliferation
ATF6a is implicated in the pathogenesis of hepatocellular carcinoma,
and overexpression of nATF6a in an HCC cell line increased gene
expression of cell cycle associated genes [131]. In two colorectal
cancer tumor banks, increased ATF6a expression was associated with
reduced disease-free survival [117]. To explore the mechanism, a
mouse model was generated with tissue specific overexpression of
active nuclear nAtf6a in intestinal epithelial cells. These mice devel-
oped spontaneous colon cancer by 12 weeks of age, with increased
proliferation of epithelial cells [117]. The mechanism was determined
to be through an increase in gut permeability leading to inflammatory
bacterial penetration into the gut wall, which activated Stat3 and led to
cancer [117]. In endothelial cells, ATF6a was found to activate a novel
target, aB-crystallin, which was pro-proliferative via a mechanism
involving VEGF [119].
6.3. Atf6a influences cell cycle entry in non-transformed cells
Emerging evidence suggests that UPR pathways in general, and Atf6a
specifically, have previously unrecognized roles in normal organ
development and function [1]. Deletion of both Atf6a and Atf6b is
embryonic lethal [42]. To date, most evidence implicating Atf6a in
proliferation in normal tissues comes from neuro-endocrine type cells
such as neurons, ovarian granulosa cells and pancreatic beta cells, or
mesenchymal cells such as cartilage, vascular smooth muscle and
cardiomyocytes. The involvement of Atf6a in expansion of tissue cell
number in response to tissue load stress is an interesting paradigm
linking organ structure with function [123]. In each case, tissue growth
may be beneficial or maladaptive.
6.4. Atf6a promotes proliferation in endocrine cells and neurons
Unresolved ER stress contributes to diabetic decompensation, both
through tissue insulin resistance in type 2 diabetes [132] and
impaired beta cell insulin secretory capacity in type 1 and type 2
diabetes [2]. ER stress negatively impacts insulin production capacity
through both impaired insulin synthesis and increased beta cell death
[2]. However, modest physiological levels of ER stress may play a role
in the adaptive increase in beta cell number that occurs in response
to insulin demand [123,133]. During increased insulin demand in
various physiological conditions (misfolding of pro-insulin, high fat
feeding, hyperglycemia) beta cells showing activation of the UPR
were more likely to enter the cell cycle [123]. Stress-associated beta
cell proliferation was lost if ER stress was reduced using molecular
chaperones, or by chemical inactivation or gene knockdown of Atf6a
[123]. Conversely, overexpression of Atf6a was sufficient to drive
proliferation in glucose-permissive conditions [123]. The mechanism
by which Atf6a promotes proliferation in beta cells is not yet known,
but a proliferative role for Atf6a has been observed in other endo-
crine cells as well. In ovarian granulosa cells, knockdown of Atf6a
arrested cells in S-phase, and caused a reduction in mRNA of cell
cycle drivers cyclin A1, cyclin B1 and cyclin D2 [92]. Atf6a may also
play an intriguing toxic-proliferation role in the Huntington’s neuro-
degenerative disorder. Neurons are post-mitotic and cannot
tolerate cell cycle entry. In both mouse models and human disease,
Atf6a processing was found to be altered, leading to accumulation of
full length Atf6a, loss of the small GTPase Rheb, and inappropriate
accumulation of cell cycle drivers which resulted in neuronal cell
death [124].
6.5. Atf6a promotes proliferation in mesenchymal cells such as
cartilage and smooth muscle
Atf6a and Atf6b are expressed throughout the proliferating and hy-
pertrophic zones of cartilage development [125]. Metaphyseal chon-
drodysplasia type Schmid (MCDS) is an ER stress-associated dwarfism
syndrome caused by mutations in type X collagen [46]. Overexpression
of mutant collagen increased both Atf6a and Atf6b activation in HeLa
cells. Ablation of Atf6a in vitro diminished cellular transcriptional
response to stress, and ablation of Atf6a in vivo in MCDS mice
worsened the disease phenotype, with expansion of the growth plate
hypertrophic zone, decreased bone growth and increased Ire1 and
Perk signaling [46]. On the other hand, ablation of Atf6b in MCDS mice
decreased ER stress markers and decreased the proliferation rate of
growth plate chondrocytes [46]. Runx2, a transcription factor important
for cartilage development, transcriptionally activates the Atf6a gene
[127]. Atf6a was found to physically interact with Runx2, and Atf6a
overexpression promoted bone length increase in a long term hMSC
culture model [125,127]. On the other hand, in two cell transformed
chondrocyte cell lines, overexpression of Atf6a decreased cell cycle
entry as determined by a flow cytometry assay [128]. In human
mesenchymal stem cells, CRISPR-mediated deletion of ATF6a
decreased population doubling, Ki67 levels, and percent of cells in S-
phase, while increasing senescence markers [61]. RNAseq demon-
strated loss of a number of cell-cycle promoting genes, including the
protooncogene FOS [61]. Surprisingly, knockdown of FOS recapitu-
lated many of the effects of ATF6a deletion in hMSCs [61].
Maladaptive smooth muscle proliferation in pulmonary arterial hyper-
tension was found to be mediated by Atf6a [134]. Mild hypoxic stress
activated Atf6a; interventions that decreased Atf6a cleavage and
target activation suppressed proliferation in smooth muscle cells both
in vitro and in vivo [134]. In addition, ER stressors that increased
nuclear Atf6a in pulmonary artery smooth muscle cells increased
proliferation as measured by nucleoside analog or Ki67, an effect that
might be due to increased accumulation of intracellular iron [135].
6.6. Atf6a can also drive tissue growth through cellular
hypertrophy
Beyond increase in cell number, Atf6a may also increase tissue mass
by inducing cellular hypertrophy in chondrocytes and cardiomyocytes.
In mice, Atf6a deletion in the chondrodysplasia model described above
resulted in reduced bone growth related, in part, to loss of cell height in
the hypertrophic chondrocytes [46]. Atf6a signaling was found to be
markedly induced in two different cardiac hypertrophy models: pres-
sure overload, by transverse aortic constriction, and hypertrophy in
response to free-wheel exercise [126]. Conditional deletion of Atf6a in
cardiac myocytes decreased the hypertrophic response and caused
cardiac dysfunction in both models; the mechanism was found to be
through Atf6a induction of mTor activator Rheb [126].
7. SUMMARY AND CONCLUSIONS
Atf6a is an important stress response protein, sensing luminal ER
stress and transmitting a nuclear signal that has many cellular effects.
Canonically, in concert with other UPR pathways, Atf6a activates gene
expression of numerous ER resident proteins, resulting in enhanced
protein folding capacity, resilience to oxidative/reductive stress, and
degradation of ER luminal misfolded proteins. Activation of Atf6a can
have both pro-survival and pro-death outcomes, depending on the cell
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type and other contextual cues that largely remain to be clarified. Atf6a
is also implicated in driving tissue growth, through both proliferative
and hypertrophic responses, which can be beneficial or maladaptive
depending on the context. The literature contains numerous conflicting
conclusions and unanswered questions that require further experi-
mental investigation.
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